HPV Test

/HPV Test
­
11 05, 2015

Medical Societies Recommend HPV Test for Cervical Cancer Screening

By |May 11th, 2015|Cervical Cancer, HPV Test|Comments Off on Medical Societies Recommend HPV Test for Cervical Cancer Screening

Most cases of cervical cancer can be prevented through early detection and treatment. In 2014, the FDA approved the Roche Cobas HPV test as a primary screening tool for cervical cancer, which means it could be used before a Pap test. This is a real-time PCR-based test from Roche Diagnostics with 16 primers that targets [...]

24 04, 2015

Cervical Cancer Screening Market – Global Forecast to 2020

By |April 24th, 2015|Cervical Cancer, HPV Test|Comments Off on Cervical Cancer Screening Market – Global Forecast to 2020

According to a recent report from Markets and Markets, the cervical cancer screening market is expected to reach $22 billion by 2020 from $15 billion in 2014, at an estimated CAGR of 7.0% from 2015 to 2020. End users of this market are hospitals, laboratories, independent physicians' offices and clinics. Factors driving this global market [...]

8 08, 2014

Will HPV Tests Replace Pap Smears?

By |August 8th, 2014|HPV Test, Roche|Comments Off on Will HPV Tests Replace Pap Smears?

According to data released by the National Cancer Institute, about 12,000 women in the U.S. were diagnosed with cervical cancer in 2014, and the disease has claimed the lives of about one-third of them. For several decades, the Pap smear had been the only tool to screen for cancer in asymptomatic women. In the Pap [...]